Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma.
Oncotarget
; 8(43): 74188-74208, 2017 Sep 26.
Article
in En
| MEDLINE
| ID: mdl-29088778
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Oncotarget
Year:
2017
Document type:
Article
Affiliation country:
Singapore
Country of publication:
United States